Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

415 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 209
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +47.9%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04662879	Early Detection Initiative for Pancreatic Cancer(EDI)	active not recruiting	N/A	8,869	Pancreatic Cancer Action NetworkOTHER	1	Sep 8, 2026	clinicaltrials
NCT02757859	WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer	active not recruiting	N/A	845	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	May 29, 2026